A Study to Evaluate the Efficacy and Safety of Faricimab in Participants With Neovascular Age-Related Macular Degeneration (LUCERNE)
Clinical trial NCT03823300 · COMPLETED
Trial details
- NCT number
- NCT03823300
- Sponsor
- Hoffmann-La Roche
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2019-03-11
- Primary completion
- 2020-10-05
- Enrollment
- 658
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.